Cardax to Lead Plenary Session at Regenerative Medicine Conference
(7 months ago)
HONOLULU: Cardax, Inc. (OTCQB:CDXI) announced today that it will lead the opening Plenary Session and participate in other key presentations at the opening session of Pacific Regenerative Medicine Conference being held November 6-7, 2017 in Honolulu, Hawaii.
The Plenary Session is titled "The Emerging Role of Anti-Inflammatory Treatment Modalities in Chronic Disease and Aging," is certified as continuing medical education (CME) for physicians, and will feature the following speakers and topics:
•Jon L. Ruckle, MD, Cardax acting Chief Medical Officer and clinical trial consultant
◦Topic: Inflammation and Cardiovascular Disease Risk
•Gilbert M. Rishton, PhD, Cardax Chief Science Officer
◦Topic: Possible Anti-Inflammatory Modalities for Cardiovascular Health
•Bradley J. Willcox, MD, Cardax collaborative researcher and consultant
◦Topic: Inflammaging: The Link Between Inflammation, Cardiovascular Disease, and Aging
Cardax CEO David G. Watumull will also participate in a panel discussion: "What Medical Tourism Means to a Local Economy."
"Our participation in this conference aligns well with our strategy to raise awareness within the medical community of the need for safe anti-inflammatory strategies to optimize health and longevity," said Cardax CEO David G. Watumull. "It also demonstrates the global role Hawaii can play as a Center of Excellence for inflammatory health and anti-aging."
The conference is being held at the Hawaii Convention Center and more information can be found at: www.pacificregenerativeconference.com. Cardax helped organize the conference and is a Platinum Sponsor.